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Normal human keratinocytes in culture exhibit a 
nitric oxide synthase (NOS) activity ranging from 50 
to 150 pmollmin/mg of protein. The enzyme is cyto-
solic and requires the presence of calcium, nicotin-
amide adenine dinucleotide phosphate, reduced form 
(NADPH), and flavin' adenine dinucleotide. Calmod-
ulin antagonists (trifluoperazine and calmidazoliUlo) 
inhibit the enzyme activity. We show that N G -nitro-
L-arginine inhibits NOS more potently than N G _ 
monomethyl-L-arginine and that L-canavanine is a 
weak inhibitor. NOS was partially purified using a 
2' ,5'-ADP Sepharose affinity column eluted with 
N itric oxide (NO) is syn th esized from L-a rginine, nicotinamide adenine dinucleotid e P ll0SPhat.e re -duced fo rm (NADPH) , and mol ecular oxygen b y nitri c ox ide synth ase (NOS) (Marietta , '1994; Na than and Xie, 1994; Schmidt and Wa lte r , 1.994; 
Stam le r, 1994) . T hl'ee iso form s of the e n zym e h ave been rep o rted: 
(i) the n e urona l isoform (bNOS) is cytoso li c and constitu tive, and 
the monom e r h as a M ,. of 150,000 -1 60 ,0 00; (ii) the e ndotheli ;,ll 
isoform (ecNOS) is m em bran e bound and constitutive, and the 
monom e r has a M,. of 135,000; :md (iii) the induc ible isofo rl11 
(iNOS) is . fou nd primaril y in murin e mac ro phage and has a M,. of 
130,000. In e pide rmis, human ke ratin ocytes ha ve been fo und to 
express th e indu cible iso form of NOS (l-leck e/ ai, 1992). III lIi/ro, 
n orma l human keratino c ytes, after stimulatio n b y tu m or n ecrosis 
factor-a, inte rfe ro n - y, o r a combinati o n of both, r e leased NO as 
detected b y an increase of th e amount of ni t ri tes in the c ultut'e 
m e dium . Fur the rm o re , th e ligation of th e low-afti ni ty receptor fo r 
IgE (C D 23), expressed at the sur face of human epidermal kerati-
n ocytes, b y IgE/anti-lgE immun e co mpl ex activated the n itri c 
oxide p athw ay (B ech e rc l et: ai, 1994). III IIi llO, th e ex pressio n of 
iNOS mRNA h as been assoc iated with psoria ti c skin les ion (Kolb-
Bach ofcn e/ ai, 1994 ) . R ecently, hum an kera tinocytes d e ri ved frorn 
an epide rmal squamou s ceU carc in o ma (S CC- 13 cell line) have 
been shown to conta in it constitutive but uncharactet;zed NOS 
isofo rm (De licon sta ntin os c/ ai, '1995) . Sin ce li t tl e is k n own about 
the presen ce of a con stitutive isoforrn of N OS in norma l hum a)l 
ke ratinocytes, th e presen t study was co nduc ted to d etermil) e 
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NADPH. A partially purified fraction was analyzed by 
sodium dodecyl sulfate-polyacrylamide gel electro-
phoresis and Western blotting. A protein with an 
apparent molecular weight of 152 kDa cross-reacted 
with lTIonoclonal antibodies raised against the neuro-
nal constitutive isoform of NOS. The enzyme had a 
V max of 7.3 nmol/min/mg of protein and a K1l1 for 
L-arginine of 22.3 /LM. These results indicate that 
normal human keratinocytes contain a constitutive 
nitric oxide synthase related to NOS I. ] Invest D el'llla-
tot 106:428-431, 1996 
whether normal human keratinocytes consti tutive ly express NOS . 
Activ ity was assayed by m easuring tbe conversion of L-[' "C]argi-
nine to L-[ "' C ]c itrulline and th e e n zym e ch aracterized by W estern 
bl ot. In addition , we investigated the subcellula r localization, the 
e Ucct of NOS inhibitors, and the req uirem e nt for cofactors. 
MATERIALS AND METHODS 
Chemicals L- IU-'''CJarginine (3'17 mC i/ 111mo l) and L-[gllanido-
"' C Jarginine (55.1 mCi/ mmol) we re pllrchased from DuPont/ NEN (Bos-
ton, MA). (GR)-5,G,7,8 ,- tetrah ydrobiopteri n (BH.,) was provided by 
Schircks Laboratories Oona , Switzerland). Leupeptin , pepstatin A, and 
ca lmodu lin were from Boehringer (Mannhcim, German y) . 0 - and L-
nitroarginine (NNA) , D- and L-ni troarginine- methyl ester (NAME), D-
and L-mo11 omethyl arginine (NMMA), and L-canavanine wcre from Alexis 
Biochemica ls (Lalifelfingen , Switzerland). 2', 5' -ADP Scpharose 4B was 
obtained from Pharmacia (Upl'sal", Sweden). Monoclonal mouse IgG raised 
aga inst bN OS. iNOS. and ecNOS were pl1l'chascd fro m Affiniti Research 
Products (Nottingham, U.K.). L-arginine, ca lmodulin antagonists W5 
[N-(G-aminohcxyl)- 'I-naphtha lene- sul fo namide], W1 3 (N-(4-aminobutyl)-
5-chlo ro- 2-naphtha lcne-sulfo namide], Trifluoperaz ine. and calmidazolium, 
;I!ld other reagents were purchased (yom Sigma Chemica l C o. (St. Louis, 
MO). 
Cell Culture Primary hunum keratinocytes obtained from Promocell 
(Heidelberg, Ge rmany) we re grown in modified MCDn 153 medium 
witho ut pheno l red, supplemented with bovine pituitary extract 0.4% 
(vol/vo l), hu man recombinant epidermal growth fac tor 0. 1 ng/ml . insulin 
5 f.Lg / ml , hydrocorti sone 0.5 ng/ml, gent:nn ycin 50 f.Lg/ml , and amphoter-
icin 13 50 ng/m l. NOS activ ity was measured on cell s at subconfluence. All 
experiments werc perfo rmed with ce lls at the third passage. T he epithelial 
n"tl1re of hu man keratinocytcs w as confirmed by immunocytochemistry 
using rabbit IgG r<l iscd against human keratins (Dako corpo ration). More 
than 99% of cell s were st:,ined with cytokeratin "ntibodies. 
Preparation of Subcellular Fractions from Normal Human Kerati-
lloeytes 1-1 uman keratinocytcs were scraped off the dishes and homoge-
nized in icc-cold lys is buffer consisting of 50 mM T ris-H C I, pH 7.5 , 1 f.LM 
Ul-C" I mM dithiotreitol , 100 f.LM e thylenediamine tetraacetic acid, 1 fLM 
leupeptin , and 1 f.LM pepstatin A. All subsequen t procedures werc carried 
o ut at 4°C. T he ce ll homogenate was centri fuged at '14,OOOg for 20 minutes. 
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The 14.000.~ pellet was was hed o nce with lysis buffer con ta.ining 'I M KC I 
and once wi th lysis bulle r w itho ut salt and then treated w ith 20 111 M 
3-[(3-cholamidopropyl) dirneth ylallllll onio'I- 'I-pro panc sul fo nic acid 
(CHAPS) in lys is hu ffe r. fo r 20 min on ice. w ith gentle shaking in OHler to 
solubilize the particulo te NOS (Mitchell cl aI, '\ 991) . T he 1 4.000.~ supe rna -
tant was incubated in the presence of Dowex AG sow-x::; (Na+ form) ('Q 
ren1QVe endogenous arg inine prio r to being subjected to a ccn tri fugc)(jo ll at 
100 ,OOUg fo r 40 min . T he pellct IV as wash cd once with lys is butte r 
conta in.ing 'I M KCI and then suspe lld l!d in lys is bufie r witho ut sa lt. T he 
pellets and the supernata nts fi'olll 14,000..: and I OO ,OOUg centrifugation we re 
all assayed fo r N OS activity. 
Assay of NOS Ac tivity NOS activity Was assayed by m easuring the 
conversion of L-l' ''CJargininc to [' ·'Cjcitrullinc. ll ri cHy. 100 /-Lg of ho ll1og-
enate pro tein Wcre incubated at pH 7.5 in a bufie r that contained 50 mM 
Tris-H CI, 1 mM N AD I'H. 15 /LM ll H." 5 /LM ilav in adenine dinucleotid l!. 
1 mM eth ylcncglyco l-bis(,B-a l1'lilloethyl ether)-N. N .N' ,N' -tetr""cetic acid 
(EGTA),3 111M CaClo, 50 U / ml c'llmodulin . 5 /-LM L-arginine, and 'IS /-LM 
L-[gu3Ilido- '''Cjarginill e o r 1 5 /-LM L-rU- " 'Cjargininc (200-,.,.1 incubation 
volu me). R.cactions Wl!re ca rri ed Oll t at :lrc fo r 30 min and stopped by 
diluting the sample in icc-cold stop bulle r 20 111M N-2-hydroxyethylpipe ra-
zine- N' -2- ethanes uHo nic acid, pH 5.5, 2 rnM EGTA . and I SO mg/ ml 
Dowex AG 50W -X8 resi n (Na + fo rm). Afte r gentl e shaking and centrifu-
ga tio n, 200 ,.,.1 of the supernatan t was mixed with '10 ml of scintillation Huid 
and the s:l111plcs counted . To 1l141kc sure that th e radioactivity coun ted to 
estimate NOS activity co rresponded to 1"'C jcitruUinc, samples trea ted w ith 
Dowex AG 50\ XI - XS Wl! re analyzed by thin-layer chro ma tography (TLC). 
Ten lui cro Hters of the s;lI11 p lc s wcn' ilnalyzed using as solven t .systenl 
etllallollacc tic acid /wate r, 4: '1 :1 . Authenti c [, ·'C jcitrulline (Rf 0.52) and 
L-[,"Clarginine (IU' 0.24 ) werl! chro matographed on the same plate . 
R-adioactivc area were dctcr111incd using Au toln atic TLC-Linca r Analyser 
(Ber thod LB-2842) . 
T h e pa rtial pUli ficatio n of 1 4,OO ().~ supernatan t was performed o n a 
2', 5 ' - ADP Sepharose co lumn equilibrated w ith lysis buffe r. Aftl! r washing 
the colul11n equilibrated with buller cont:,ining 0.5 M NaCI until no 111 0 re 
prote in e l11erged , NOS activity was eluted in lys is bufFe r supplemented w ith 
10 111 M NAD PH . Enzyme aSSays we re c:lrried o ut immediatel y after 
pm:ification as mentio ned above. except that 0.5- 2 /-Lg of ho mogenate 
pro tein from thl! e lu ted fracti ons were incubated in tIll! presenCl! of 2. 3, 5, 
to, a nd 100 ,.,.M of L-l" 'CjL-arginine for 1-4 m in in order to dete rmine K", 
fo r L -arg inin e and V
IIHl X
' 
W e s te rn Blot Samples were electrophoresed o n two 7 .5'X, polyacryl-
am ide gels. O ne was sil ve r stained . and tltl! o ther was e lectroblottl!d to 
nitroce ll ulose sheets fo r 1 h using a Transblot SD electropho retic T ransfer 
cell (Bio-Rad , Richl11o nd , CA) at 2.6 mA/ cm 2 • Afte r blocking with ge latin 
3% and washing. the ni trocellulose sheet was incubated with a 1 :250 
dilution of Illonoclonal mo use IgG raised aga inst bNOS, ceNOS or iNOS 
and detected with a 1:1000 dilu tio n of alkalin e phosphatase-co njugated goat 
antibody to mo use IgG. 'We checked the specifIcity of the antibodies using 
rat b rain , hUlllan endothel ial . and mouse macrophage Iysates o btained fro m 
Tran sd uctio n La bontt:o ries. O nl y th e Illo lloclon al an tibod ies raised aga inst 
bNOS showl!d cross-reactivity w ith iNOS as mentio ned by the company. 
Protein Dcte rluinatioll Pro te in was Ill casurcd acco rdin g to the ll lc thod 
of Brad ford lI sing bovine SC rtlll1 albumin ~I S st'lndard. ....., 
R ES ULTS 
N o r mal Human Keratinocytc NOS Is Loc aliz ed in the 
Cytosol N OS activ ity in p ro te in fi' acti o ns of unstimul a ted hum an 
keratinocyte h o m ogen ates w as assayed b y m e asuring L-c itrulline 
form atio n in the presen ce of exogen o u s ca lcium and calm o dulin . 
T he pe ll e t fro m a J 4,OOO,~ cen t ri fuga ti o n resusp ende d in assay bufFe r 
with o ut o r with 20 mM C H A PS did n ot e xhibit N OS activ ity; 
hovvever , t h e superna ta n t con tained a basal N OS activi ty w ith a 
specific ac ti v ity rang in g fro m 50 to 1 50 pmol/min / m g of protein 
(data n o t sh own) . In o rde r to asce rta in that th e b asal N OS activ ity 
is re lated to a cy tosolic e n zym e, th e 1 4,000g superna tan t was 
subj ec ted to a 100 ,000g cen trifugatio n . T he d ata presen ted in 
Table I sh ow tha t m o re than 99% of N O syn t hase activ ity w as 
re covered in th e l OO,OOOg superna tan t. As N OS activ ity £i'0111 
14,OOOg superna tant w as a lm os t ide ntica l to that fro m lOO.OOO.!.' 
superna tant. a ll subsequ ent exp eriments were p e rfo rme d w ith the 
14,OOOg supe rna tan t fi·actio n. 
E ffects of Arginine Analogs 011 Human Keratinocyte NOS 
A ctivity Sin ce the constitu t ive and inducib le iso fo rms of N OS 
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Table I. Normal Hum a n Ker atinocyte NOS Is L o calized 
in the C yto sol 
Fraction Insoluhle " Soluble" 
Protein (mg) 0.03 0 .9 1 
Speci~ic NOS activ ity 10 164 
(pmol L-c itrullinc/ mg/ min) 
Total NOS activ ity 0.3 149 
(p111 01 L-c itrulline/ min) 
Distribution of NOS activity (%) 0.2 99.S 
" Insulubl e and so lu hle franions were prl'parccl and itss;tycd for NOS ;1Ctiviry :md 
prore in COl1te ll t :1 S dcsu ibed in IHflleri fl /s flJI{I Mdll en/s. Data nrc rep rcscn ta ti ve ror tluct' 
Si lllil :l l- pn..: par:l tioIlS. 
ha ve difFe re nt K; values fo r a rg in ine anal ogs, we h ave in vestigated 
th e effec t of inc re,lsin g con cen t ra tio ns of su ch inhibi to rs o n NOS 
ac ti v ity . N OS inhibitio n w as assayed as fo rm a tio n of L- c itrulline 
fi'om 2 0 J.LM L-arginine b y hum an ke ratinocytes 14,000.!,' supe m a-
tant fi·actio n . Fig 1 sh ows th a t N OS activ ity was inhibited wi th an 
IC ' (I orO.3, 2. 2.5, and 100 J.LM fo r L-NNA, L- NAME, L-NMM A, 
alld canava nin e . respective ly. We fo und tha t th e inhibi t ion of N OS 
activ ity by arg inine an alogs at 10 J.LM w as ste reosp ecific (data n ot 
sh own) . 
Huma n K e ratinocyte NOS Activ i ty Is C a 2 + and C almodulin 
D e pende nt Becau se of th e k n own requi rem en t of N ADPH as 
cos ubstrate and I3H4 , fl av in ad e nin e dinucleotide , caJ c ium , and 
C<l lmo dulin as cofactors fo r ca ta ly ti c activi ty of N OS, we have 
studi ed th e ir effect o n th e CO il ve rsio n of L- arginin e to L- c itrulliue 
from 14,000g supe rna tan t e x tract. T able II sh ows th a t th e activ ity 
of human k e ratinocyte N OS is pa rt ia ll y d e pe n dent o n th e additio n 
o f N AD PB and fl av in ade nin e dinu cleo tide. Surpri sing ly, th e 
o missio n ofB B ., d id n ot resul t in a d ecrease of NOS activ ity. W h e n 
th e re ac tio n mi xture w as n o t supple m en ted w ith calcium , NOS 
acti v ity w as completely suppressed bllt ad d itio n of calm o dulin was 
n ot re quire d . To Imow whe the r the e lFect of calcium was m ediated 
b y e ndogen o u s calm o dul in , we have examined th e efFect o f cal-
m od ulin an tagonists. Fig 2 shows that t rifluo p erazin e and calmi-
dazo lium a t a con centrat io n ofl00 J.LM almost compl etely inhib ite d 
N OS activ ity, w he reas W5 and W 13 pa r tia ll y blocked th e e n zym e 
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Figure 1, Arg inine a nalogs inhibit human k era tillocyte NOS activ -
ity . POI' NO syn thase act ivity. 100 /-Lg of ho lllOgCll il tc protein fi'o lll 1 4 , 000.~ 
supernata nt Were incubawd 30 min as described in MmeTin ls " lid Melh ods in 
th e prl!sell ce of ill creasillg cOllcentrations of L- N N A (0 ). L- NA ME (0 ). 
L-NMM A (e ). alld L-canavalline (. ). III the absence of arginine analog, 
N OS activity was abo ut 122 pmo l/ mill / mg o f prote in . 
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Table II. Human Keratinocyte NOS Activity Depends on 
the Presence of Calciuul 
Omitted Cofactor(s) 
Control 
Ca 2 + 
Call110dulin 
Ca2 + Ica lmod ulin 
NADPI-I 




(pl11ol/min/l11g of protein) 
150.4 :!:: 24.6 
4.9 :!:: 2.6 
134 :!:: 3 1.8 
5.7 ± 3.0 
53.6 ± 14.8 
83.8 ± 17.2 
128.1 ± 29.7 
150.3 ± 29 .1 










Human Keratinocyte NOS Is Related to the Constitutive 
Isoform bNOS In order to characterize th e basal NOS activity, 
a crude extract was fractionated on a 2',5'-ADP Sepharose 4B 
column. T he result of a representative purificat ion of NOS from 
14,000g supernatant is shown in Table III. Exam in ation of the 
NADPH containing eluate by sodium dodecyl sulf.1te-po lyacrylam-
ide gel electrophoresis with subsequent silver staining revealed 
several majol' bands between 45 and 66 lilla (Fig 3 , /tji prll/e/). A 
minor band corresponding to a protein of - 150 kDa is visible. To 
determine which isoform is responsible for the conversion of 
L-[guanido- I'IC]arginine to L_[ 14 C]citrulline, the eluate was exam-
ined by W estern blot for its cross-reactivity w ith monoclonal 
antibodies raised against the three isoforms (bNOS, ecNOS, and 
iNOS). The right panel of Fig 3 shows that the 152 kDa band was 
specificall y recognized by antibody to n euronal constitutive NOS. 
The Kinetic Constants of Partially Purified HUJnan Kerati-
nocyte NOS for L-Arginine The kine tic parameters of ADP 
Sepharose-fi'actionated NOS were examined. T he rate of citru lline 
format ion by 0.5-2 J1.g of partial purifi ed enzyme was conducted in 
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Figure 2. Calmodulin antagonists inhibited human keratinocyte 
NOS activity. Enzyme activity in '14,OOOg supernatant was performed as 
described in Fig 1, except that ca lmodulin was omitted. The enzyme 
activity W'IS assayed in the presence of 10 or 100 J.LM of calm odu lin 
antagonists (W5, W13, ca ll11idazoliulTI, and triiluoperazim,). Data arc 
expressed as a function of control and are the mean ± SEM of three 
indi vidua l expc rinl cl1ts. "' p < 0.05 "erslIs control. DUllctt test. 
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Table In. Partial Purification of Normal Human 
Kcratillocyte NOS on a 2',5' -ADP Sepharose Column" 
Spccitlc Tota l 
Proteins Activity Activity Purification 
FractioL1 (/.Lg) (nl1lolll11in/mg) (plllo l/ min) (fo ld) 
14,OOOg supernatant 7.680 (l."I07 823.3 
2',5'-ADP Scpharosc 
4B elua te 42 .1 5.012 2 11.1 47 
., 1):11';1 "re sc1lred arc frolll :1 ryp iC;:ll puritl cil tioll. w hi ch was rl!pc'Hcd three rillles Wirll 
similar results. 
of cofactors as desc ribed in the Materials alld M.ethods. Under these 
conditions, in itia l rates were lin ear for at least 4 min (data not 
shown). K,n and V, .. "x were ca lculated from a Lineweaver-Burke 
plot (Fig 4). The partially purified enzyme ha s a aftinity for 
L - arginine with a 1<.", 0[22.3 :!: 2.3 J1.M (mean of three independent 
experiments :!:: SEM) and a Vm"x of 7.3 :!:: 0.3 lImolimill / 111g of 
protein (mean of three independent experiments :!: SEM). 
DISCUSSION 
Our results show that uns timul ated cultured normal human kera-
tinocytes exhibit a constitutive NOS ac tivity ranging from 50 to 
150 pll10llmin/mg of protein. T he basal activity was at least 50-fold 
hi gher than previously reported for murine keratinocytes (Heck el 
ai, 1992) or other epithelial ce lls like normal hum an bronchial 
epithelial ce ll s (Asano et ai , 1994; Mannick et ai, 1994). We Call1lot 
exclude the possibility that different culture conditions account for 
the observed variations; however, depl e tion of epidermal growth 
factor, hydrocortisone, and pituitary extract did not affect NOS 
activ ity (data not shown). 
T hree NOS isoforms have been characte rized whi ch can be 
especially distinguished by thei r subce IJular localization and level of 
express ion. The first enzyme purified and cloned (Bredt and 
Snyder, 1990; Bredt et ai, 1991) was the neurona l constitutive 
isofonn, which was cytosoli c . The endothelial constitutive NOS, 
purified fi'om bovine aortic endothelial ce ll s (Pollock el ai, 1991 ), 
was particulate and bound to the membrane by its myristoylation 
site (Busconi and Mitchell , 1993). An inducible cytosol ic NOS was 


















Figure 3. Human keratinocyte 150-kDa protein cross-reacted with 
monoclonal antibodies raised against bNOS. Lift) Sodium dodecyl 
suJfa te-polyacrylamid" gel electrophoresis analysis of the '14 ,(lOOg superna-
tant and NADPH cluate fi'om the 2',5'-ADP Scpharosc 4U columBo 
Polyacrylamide gel W.1S si lve r stained. Lnllt' A. lTIo lecu lar IllaSS 111arke rs; [tllll' 
B, 1.2 J.Lg of 14,OOOg supernatant; inlle C, 1.4 J.Lg of ADP Sepharosc ti-action 
elu ted by l 0 111M NADPJ-J. R;L~hl) A second gel proteins prepared a 
indica ted nbove was transferred to nitroce ll ulose, and Western b lot ana lysis 
was performed with monoclonal antibodies raised against bNOS (Alii ; 
lie NOS) . iNOS, and ccNOS . COlltroi , molecular weigbt standards. 
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Figure 4. Lineweaver-Burke representation ofllVi I'S lI[Arginine] . 
Kinetics ofL-citrulline formation by humar) keratinocyte NO synthase as a 
function of the concentration of L-arginine. Double-reciprocal plot of 1 / Vi 
vs 1/[S]. 
1991; Stuehr el ai, 1994). When we analyzed the subcellu lar 
fractions of cul tured normal human ke ratinocytes for NOS activity, 
we fo und that more than 95% of basal NOS activity was recovered 
in the 100,000g supematant, suggesting that human keratinocyte 
NOS is mainly cytosolic. According to the classification of NOS 
mentioned above, the human keratinocyte NOS isoform cou ld be 
either the constitu tive bNOS or the inducible iNOS. 
A difference in the sensitivity of constitutive NOS (neuronal and 
endothelial isoforms) and inducible NOS to the inhibition by 
arginine analogs has been reported. The endothelial and neuronal 
enzymes are more sensitive than the inducible isofonn to inhibition 
by N G-nitro-L- arginine and its methyl ester , L-NAME (G ross el ai, 
1990; Lambert el ai, 1991). N G-monomethyl-L- argin ine appears to 
be nonselective, some arginine analogs such as L- canavanine inhibit 
the inducible macrophage NOS more than the constitutive brain 
and endothelial NOS (Lyengar et ai, 1987; Palmer el ai, 1988) . Our 
experiments performed with various of the above inhibitors suggest 
that normal human keratinocyte NOS is a constitutive enzyme. 
To confirm this hypothesis, we investigated the en zymes depen-
dency on calcium/ca lmodu lin . Indeed, the constitutive NOS activ-
ities were increased in the presence of calcium elevating agonists. 
The transient increased calcium bound to ca lmodulin, which in turn 
activated the enzyme by binding to it. [n contrast, the level of 
inducible NOS was regul ated by its expression and th e present 
intracellular calcium sufficient for its activation. Our study shows 
that normal human kerati.l1ocyte N OS had an absolu te requirement 
for calcium but did not require the addition of calmodulin. Its 
activity was inhibited after addition of calmodulin antagonists, 
however, suggesting that endogenous calmodulin was not lost 
during the subcell ular fractionation. The calcium/calmodu lin de-
pendency of the enzyme provides further support for the finding 
that NOS in cultured human kera tinocytes is constitu tive . Surpris-
ingly, we found no dependency of the enzyme activity on exoge-
nous BH •. One explanation could be the recent finding that 
undiffereJltiated human keratinocytes expressed high levels of BH. 
(Schallreuter ct ai, 1995). 
In conclusion, we demonstrated here that no[mal human kera-
tinocytes in culture express a cytosolic NO synthase activity. Bascd 
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on our inhibition and activation experimcnts, we con clude that this 
keratinocyte NOS is a constitutive NOS related to bNOS (or NOS 
1 according to the numeric nomenclature) as revealed by its 
cross-reactivity with antibodies raised aga inst the n euronal isoform. 
The factors that control. normal human keratinocyte NOS activity 
and its physiological ro le remain to be determined. Experimenrs to 
answer these questions are in progress . 
ItVe Ihallk Ms. TsalJellc Rellalllf .fin her help ill pr('p(/rill.~ (his IIwllll script. I Vc also 
gn,aliy appreciate the hcl!!lir! WIII/II,'IIIS (!F Dr. R. Schlllidt . 
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